Found: 7
Select item for more details and to access through your institution.
In vivo-in vitro Model to Assess Chloroquine Activity in Monkeys.
- Published in:
- Chemotherapy (0009-3157), 1995, v. 41, n. 2, p. 134, doi. 10.1159/000239334
- By:
- Publication type:
- Article
Titelbild: Artemisone—A Highly Active Antimalarial Drug of the Artemisinin Class (Angew. Chem. 13/2006).
- Published in:
- Angewandte Chemie, 2006, v. 118, n. 13, p. 2041, doi. 10.1002/ange.200690045
- By:
- Publication type:
- Article
Artemisone—A Highly Active Antimalarial Drug of the Artemisinin ClassWork at the HKUST was funded by Bayer AG Central Research, Leverkusen, the Institute of Molecular Technology for Drug Discovery and Synthesis through the HKSAR University Grants Committee Areas of Excellence Fund, and the HKSAR Research Grants Council through the Competitive Earmarked Research Grants Scheme. The Medicines for Malaria Venture (MMV), Geneva, also provided financial support of the work at Bayer, and through Bayer at HKUST and other centers. Dr. W. Collins (Centers for Disease Control, Atlanta) supplied P. falciparum FVO strain used for the primate studies.
- Published in:
- Angewandte Chemie, 2006, v. 118, n. 13, p. 2136, doi. 10.1002/ange.200503071
- By:
- Publication type:
- Article
Army Malaria Institute - its Evolution and Achievements. Fourth Decade (1st Half): 1995-2000.
- Published in:
- Journal of Military & Veterans' Health, 2014, v. 22, n. 1, p. 30
- By:
- Publication type:
- Article
Army Malaria Institute - its Evolution and Achievements Third Decade (2nd Half) : 1990-1995.
- Published in:
- Journal of Military & Veterans' Health, 2013, v. 21, n. 2, p. 36
- By:
- Publication type:
- Article
Cover Picture: Artemisone—A Highly Active Antimalarial Drug of the Artemisinin Class (Angew. Chem. Int. Ed. 13/2006).
- Published in:
- Angewandte Chemie International Edition, 2006, v. 45, n. 13, p. 1989, doi. 10.1002/anie.200690045
- By:
- Publication type:
- Article
Artemisone—A Highly Active Antimalarial Drug of the Artemisinin ClassWork at the HKUST was funded by Bayer AG Central Research, Leverkusen, the Institute of Molecular Technology for Drug Discovery and Synthesis through the HKSAR University Grants Committee Areas of Excellence Fund, and the HKSAR Research Grants Council through the Competitive Earmarked Research Grants Scheme. The Medicines for Malaria Venture (MMV), Geneva, also provided financial support of the work at Bayer, and through Bayer at HKUST and other centers. Dr. W. Collins (Centers for Disease Control, Atlanta) supplied P. falciparum FVO strain used for the primate studies.
- Published in:
- Angewandte Chemie International Edition, 2006, v. 45, n. 13, p. 2082, doi. 10.1002/anie.200503071
- By:
- Publication type:
- Article